NewAmsterdam Pharma Co N.V. Weighted Average Number of Shares Outstanding, Basic from 2021 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
NewAmsterdam Pharma Co N.V. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from 2021 to Q3 2025.
  • NewAmsterdam Pharma Co N.V. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2025 was 119M shares, a 25.6% increase year-over-year.
  • NewAmsterdam Pharma Co N.V. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 94.4M shares, a 14.8% increase from 2023.
  • NewAmsterdam Pharma Co N.V. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 82.2M shares, a 333% increase from 2022.
  • NewAmsterdam Pharma Co N.V. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 19M shares, a 72.8% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)

NewAmsterdam Pharma Co N.V. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 119M +24.2M +25.6% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-05
Q2 2025 119M +23.8M +25.2% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-06
Q1 2025 116M +27.7M +31.4% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-08
Q4 2024 94.4M +12.2M +14.8% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-26
Q3 2024 94.8M +12.3M +14.9% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-05
Q2 2024 94.7M +12.6M +15.4% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-06
Q1 2024 88.4M +6.75M +8.26% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-08
Q4 2023 82.2M Oct 1, 2023 Dec 31, 2023 10-K 2025-02-26
Q3 2023 82.5M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 82.1M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 81.6M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08

NewAmsterdam Pharma Co N.V. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 94.4M +12.2M +14.8% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-26
2023 82.2M +63.2M +333% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-26
2022 19M +7.99M +72.8% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-26
2021 11M Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.